US Patent Issued to SAMJIN PHARMACEUTICAL, INCHEON NATIONAL UNIVERSITY RESEARCH & BUSINESS FOUNDATION, BAMICHEM on March 31 for "Adamantane derivatives as inhibitors of focal adhesion kinase" (South Korean Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,070, issued on March 31, was assigned to SAMJIN PHARMACEUTICAL Co. LTD. (Seoul, South Korea), INCHEON NATIONAL UNIVERSITY RESEARCH & BUSINESS FOUNDATION (Incheon, South Korea) and BAMICHEM Co. LTD. (Incheon, South Korea).

"Adamantane derivatives as inhibitors of focal adhesion kinase" was invented by Min Hyo Ki (Seongnam-si, South Korea), Ho Seok Kwon (Suwon-si, South Korea), Young Hun Lee (Seoul, South Korea), Eunsun Song (Seongnam-si, South Korea), Yong Bin Park (Anyang-si, South Korea), Kug Hwa Lee (Yongin-si, South Korea), Hyoung Min Cho (Seongnam-si, South Korea), Soon Kil Ahn (Seoul, South Korea), Sung Pyo Hong (Yeonsu-gu, South Korea) and Sung Hye Kim (Yeonsu-gu, South Kor...